A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control

Diabetes Obesity and Metabolism ◽

10.1111/dom.14331 ◽

2021 ◽

Author(s):

Takashi Kadowaki ◽

Yutaka Seino ◽

Kohei Kaku ◽

Taro Okamoto ◽

Miho Kameya ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Therapy ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study

Diabetes Obesity and Metabolism ◽

10.1111/dom.13397 ◽

2018 ◽

Vol 20 (10) ◽

pp. 2490-2493 ◽

Cited By ~ 2

Author(s):

Kohei Kaku ◽

Shingo Kuroda ◽

Kazuyuki Ishida ◽

Yuusuke Umeda

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase Iv

Download Full-text

Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study

Diabetes Therapy ◽

10.1007/s13300-019-00726-8 ◽

2019 ◽

Vol 11 (1) ◽

pp. 133-145 ◽

Cited By ~ 1

Author(s):

Hitoshi Ishii ◽

Yukiko Onishi ◽

Tomonori Oura ◽

Masakazu Takeuchi

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Controlled Study ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 35

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2010.01222.x ◽

2010 ◽

Vol 12 (8) ◽

pp. 700-708 ◽

Cited By ~ 55

Author(s):

Y. Iwamoto ◽

A. Kashiwagi ◽

N. Yamada ◽

S. Terao ◽

N. Mimori ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study (the SPOTLIGHT study)

Diabetology International ◽

10.1007/s13340-014-0182-y ◽

2014 ◽

Vol 6 (2) ◽

pp. 104-116 ◽

Cited By ~ 30

Author(s):

Atsunori Kashiwagi ◽

Takanori Shiga ◽

Noriko Akiyama ◽

Kenichi Kazuta ◽

Atsushi Utsuno ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12957 ◽

2017 ◽

Vol 19 (10) ◽

pp. 1397-1407 ◽

Cited By ~ 23

Author(s):

Yasuo Terauchi ◽

Masahiro Tamura ◽

Masayuki Senda ◽

Ryoji Gunji ◽

Kohei Kaku

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Multicentre Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12853 ◽

2017 ◽

Vol 19 (4) ◽

pp. 562-570 ◽

Cited By ~ 19

Author(s):

Eiichi Araki ◽

Yukiko Onishi ◽

Michiko Asano ◽

Hyosung Kim ◽

Toshitaka Yajima

Keyword(s):

Type 2 Diabetes ◽

Insulin Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Therapy Trial

Download Full-text

Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12235 ◽

2013 ◽

Vol 16 (5) ◽

pp. 418-425 ◽

Cited By ~ 32

Author(s):

T. Kadowaki ◽

K. Kondo

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period

Current Medical Research and Opinion ◽

10.1080/03007995.2018.1441816 ◽

2018 ◽

Vol 34 (6) ◽

pp. 981-994 ◽

Cited By ~ 7

Author(s):

Yutaka Seino ◽

Takashi Sasaki ◽

Atsushi Fukatsu ◽

Hisae Imazeki ◽

Hidekazu Ochiai ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Study ◽

Insulin Therapy ◽

Japanese Patients ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind

Download Full-text